Keywords: evotec, acquires, rest, ens, secures, 47m, euros

Evotec acquires rest of ENS and secures 47M euros to develop CNS pipeline

Article | 14 March 2005

Print This

German drug discovery and development firm Evotec OAI AG says it is acquiring the outstanding 78% of Evotec Neurosciences (ENS) that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in